Intervention not reported
Any adverse event · critically ill patients
1 finding from 1 review
Intervention not reported
Mortality · critically ill patients
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Economic outcomes · critically ill patients
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Hospital admissions · people with heart failure with reduced ejection fraction
Nurse‐led titration leads to lower all‐cause hospital admissions compared with usual care (high certainty).
1 finding from 1 review
Heart failure hospitalisation (RR) · people with heart failure with reduced ejection fraction
Nurse‐led titration probably leads to lower heart failure‐related hospital admissions compared with usual care (moderate certainty).
1 finding from 1 review
All‐cause mortality · people with heart failure with reduced ejection fraction
Nurse‐led titration probably leads to lower all‐cause mortality compared with usual care (moderate certainty).
1 finding from 1 review
All‐cause event‐free survival · people with heart failure with reduced ejection fraction
Nurse‐led titration probably leads to lower all‐cause event‐free survival compared with usual care (moderate certainty).
1 finding from 1 review
Proportion reaching target dose of medications · people with heart failure with reduced ejection fraction
Nurse‐led titration may leads to higher proportion reaching target dose of medications compared with usual care (low certainty).
1 finding from 1 review
Intervention not reported
Pain (at study completion) WOMAC (VAS or NRS) from 0 to 20; lower scores mean reduced pain · People with hip or knee osteoarthritis
1 finding from 1 review
Intervention not reported
Physical function (at study completion) WOMAC (self administered health status measure) from 0 to 68; lower scores mean better function · People with hip or knee osteoarthritis
1 finding from 1 review
Intervention not reported
Quality of life (at study completion) EuroQol (VAS) from 0 to 200 mm; higher score means better function · People with hip or knee osteoarthritis
1 finding from 1 review
Intervention not reported
Adverse effects (related to the exercise programs) · People with hip or knee osteoarthritis
It is very uncertain whether the intervention changes adverse effects (related to the exercise programs) (very low certainty).
1 finding from 1 review
Intervention not reported
Severe adverse events or withdrawals (due to adverse events) ‐ not reported · People with hip or knee osteoarthritis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pain ‐ duration exercise WOMAC (VAS or Likert) from 0 to 20 · Patients with osteoarthritis of the knee or hip
1 finding from 1 review
Pain ‐ resistance exercise WOMAC (VAS or Likert) from 0 to 20 · Patients with osteoarthritis of the knee or hip
1 finding from 1 review
Function ‐ duration exercise WOMAC from 0 to 68 · Patients with osteoarthritis of the knee or hip
1 finding from 1 review
Function ‐ resistance exercise WOMAC from 0 to 68 · Patients with osteoarthritis of the knee or hip
1 finding from 1 review
Intervention not reported
Total mortality Systolic targets · Diabetes Mellitus with elevated blood pressure
The intervention showed no clear difference in total mortality Systolic targets (low certainty).
1 finding from 1 review
Intervention not reported
Total mortality Diastolic targets · Diabetes Mellitus with elevated blood pressure
It is very uncertain whether the intervention changes total mortality Diastolic targets (very low certainty).
1 finding from 1 review
Intervention not reported
Total serious adverse events Systolic targets · Diabetes Mellitus with elevated blood pressure
The intervention showed no clear difference in total serious adverse events Systolic targets (low certainty).
1 finding from 1 review